SEC Form D · filed October 18, 2018
PHOENIX BIOTECHNOLOGY INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
Jeffrey S. Thompson · San Antonio, TXDirectorRobert A. Newman · San Antonio, TXExec · DirectorCrandell Addington · San Antonio, TXExec · DirectorJohn W. Creamer · San Antonio, TXDirectorLou T. Kost · San Antonio, TXExec · DirectorMacdonald T. Haskell · San Antonio, TXDirectorAndrew J. Butler · San Antonio, TXDirectorGreg F. Gruning · Cuyahoga Falls, OHExec · DirectorStephen S. Sypherd · Philadelphia, PADirectorMark Hauser · New York, NYDirectorW. M. Bryant · Louisville, KYDirectorTadataka M. Yamada · Seattle, WAExec · DirectorGary T. Salhany · Cuyahoga Falls, OHExec · DirectorDavid W. Davis · Louisville, KYDirectorRichard G. Kent · London, United KingdomDirectorFrank Sena · SEATTLE, WADirectorRobb Monkman · SEATTLE, WADirectorBrian K. Sullivan · Canton, GAExec · DirectorChris Allen · Alpharetta, GAExec · DirectorIgniteXL Ventures GP, LLC · Palo Alto, CADirectorMichael Hacke · Pittsburgh, PAExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗